US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Evotec SE - American Depositary Shares (NQ:EVO)

1.660 +0.060 (+3.75%)
Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evotec SE - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Carvana, Designer Brands, REV Group And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded higher, with the Nasdaq Composite rising around 70 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Evotec Presents Sustainability Strategy
Via ACCESSWIRE
News headline image
Evotec Receives Grant from Open Philanthropy for Discovery of RNA-Targeting Henipavirus Therapeutics
Via ACCESSWIRE
News headline image
Just - Evotec Biologics Enters Strategic Biosimilars Partnership with Sandoz
Via ACCESSWIRE
News headline image
Just - Evotec Biologics Launches Tech Partnership for Biosimilars Development and Commercial Manufacturing
Via ACCESSWIRE
News headline image
Evotec SE Provides Update on Cyber Attack
Via ACCESSWIRE
News headline image
Earnings Preview For Evotec ↗
 
Via Benzinga
News headline image
Cyber Attack on Evotec
Via ACCESSWIRE
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023 ↗
 
Via Benzinga
News headline image
Evotec and Bristol Myers Squibb Extend and Expand Strategic Neurodegeneration Partnership
Via ACCESSWIRE
News headline image
Evotec SE Preliminary Fiscal Year 2022 Results: 'Ahead of the Curve' - Very Strong Performance in a Challenging Year
Via ACCESSWIRE
News headline image
Evotec Receives US$ 6.6 m Grant for Drug Discovery in Tuberculosis
Via ACCESSWIRE
News headline image
Evotec SE to Announce Preliminary Financial Results for Fiscal Year 2022 on 28 March 2023
Via ACCESSWIRE
News headline image
Evotec Announces Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
Via ACCESSWIRE
Sernova Corp. (TSX: SVA) Featured in Coverage of the 35th Annual Roth Conference
Via Investor Brand Network
News headline image
Evotec Receives € 150 m Loan from European Investment Bank
Via ACCESSWIRE
News headline image
Evotec and Related Sciences Expand Integrated Drug Discovery and Development Partnership
Via ACCESSWIRE
News headline image
Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer
Via ACCESSWIRE
News headline image
Evotec Announces Agreement with Janssen to Develop Immune-Based Therapies
Via ACCESSWIRE
News headline image
Evotec Achieves Further Progress in Neuroscience Collaboration with Bristol Myers Squibb
Via ACCESSWIRE
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022 ↗
Upgrades 
Via Benzinga
News headline image
CarGurus, Disney, Upstart And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Merrimack Pharmaceuticals (NASDAQ:MACK) shares rose 180.0% to $11.2 during Wednesday's pre-market session. The company's market cap stands at $150.1 million. As per the news, the Q3 earnings... 
Via Benzinga
News headline image
Why Array Technologies Shares Are Trading Sharply Higher; Here Are 28 Stocks Moving Premarket ↗
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares jumped 32% to $1.65 in pre-market trading. NeuroBo reported closing of $32.3 million underwritten public offering including full exercise of... 
Via Benzinga
News headline image
Evotec SE Reports Results for the First Nine Months 2022 and Provides Corporate Update
Via ACCESSWIRE
News headline image
Evotec SE to Announce Results for the First Nine Months 2022 on 09 November 2022
Via ACCESSWIRE
News headline image
Evotec Completes Acquisition of Central Glass Germany
Via ACCESSWIRE
News headline image
Evotec Presents Paradigm Shift in Biologics at Capital Markets Day
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 10 Next >